PAULA OHIKU: Open Payments
NPI 1215185327 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 24 payments from 10 companies in 2025. Trend: 2023 $98 · 2024 $259 · 2025 $749
Food & beverage: $670Education: $80
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $206 |
| Vanda Pharmaceuticals Inc. | 4 | $182 |
| Lundbeck LLC | 4 | $81 |
| Indivior Inc. | 2 | $72 |
| Exact Sciences Corporation | 2 | $55 |
| Globus Medical, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $36 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: UZEDY, FANAPT, ABILIFY ASIMTUFII, SUBLOCADE, HETLIOZ, Cologuard Collection Kit, Senza, Auvelity.
Industry payments across MD — which companies pay providers there.
